Comparison and relationship of thyroid hormones, IL-6, IL-10 and albumin as mortality predictors in case-mix critically ill patients  by Quispe E, Álvaro et al.
Cytokine 81 (2016) 94–100Contents lists available at ScienceDirect
Cytokine
journal homepage: www.journals .e lsevier .com/cytokineComparison and relationship of thyroid hormones, IL-6, IL-10 and
albumin as mortality predictors in case-mix critically ill patientshttp://dx.doi.org/10.1016/j.cyto.2016.03.004
1043-4666/ 2016 The Authors. Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Abbreviations: AUC, area under the curve; APACHE II, Acute Physiology and
Chronic Health Evaluation II; EICU, emergency intensive care unit; ICU, intensive
care unit; IFN, interferon; IL, interleukin; LT3, Low T3 syndrome; NTIS, nonthyroidal
illness syndrome; FT3, Free Triiodothyronine; ROS, reactive oxygen species; ROC
curve, receiver operating characteristic curve; rT3, reverse Triiodothyronine; T3,
Triiodothyronine; T4, Thyroxine; TNF, tumor necrosis factor; TSH, thyroid-
stimulating hormone; TT3, total Triiodothyronine; TT4, total Thyroxine; TH, thyroid
hormones; TBG, Thyroxine Binding Globulin.
⇑ Corresponding author.
E-mail address: lxm8229@126.com (X.-M. Li).Álvaro Quispe E a, Xiang-Min Li a,⇑, Hong Yi b
a Emergency Intensive Care Unit, Emergency Department of Xiangya Hospital – Central South University, 87 Xiangya Road, Changsha 410008, China
bDepartment of Molecular Biology, Xiangya Hospital – Central South University, 87 Xiangya Road, Changsha 410008, China
a r t i c l e i n f o a b s t r a c tArticle history:
Received 15 August 2015
Received in revised form 26 February 2016
Accepted 7 March 2016
Available online 11 March 2016
Keywords:
Thyroid hormones
Cytokines
Albumin
MortalityObjective: To compare the ability of thyroid hormones, IL-6, IL-10, and albumin to predict mortality, and
to assess their relationship in case-mix acute critically ill patients.
Methods: APACHE II scores and serum thyroid hormones (FT3, FT4, and TSH), IL-6, IL-10, and albumin
were obtained at EICU admission for 79 cases of mix acute critically ill patients without previous history
of thyroid disease. Patients were followed for 28 days with patient’s death as the primary outcome. All
mean values were compared, correlations assessed with Pearson’ test, and mortality prediction assessed
by multivariate logistic regression and ROC.
Results: Non survivors were older, with higher APACHE II score (p = 0.000), IL-6 (p < 0.05), IL-10
(p = 0.000) levels, and lower albumin (p = 0.000) levels compared to survivors at 28 days. IL-6 and
IL-10 had significant negative correlation with albumin (p = 0.001) and FT3 (p 6 0.05) respectively, while
low albumin had a direct correlation with FT3 (p < 0.05). In the mortality prediction assessment, IL-10,
albumin and APACHE II were independent morality predictors and showed to have a good (0.70–0.79)
AUC-ROC (p < 0.05). Despite that the entire cohort showed low FT3 serum levels (p = 0.000), there was
not statistical difference between survivors and non-survivors; neither showed any significance as
mortality predictor.
Conclusions: IL-6 and IL-10 are correlated with Low FT3 and hypoalbuminemia. Thyroid hormones
assessed at EICU admission did not have any predictive value in our study. And finally, high levels of
IL-6 and IL-10 in conjunction with albumin could improve our ability to evaluate disease’s severity
and predict mortality in the critically ill patients. When use in combination with APACHE II scores, our
model showed improved mortality prediction.
 2016 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Since the development of the ‘‘acute physiology and chronic
health evaluation II” (APACHE II) [1], mortality prediction in criti-
cally ill patients remains a great concern for physicians and
patient’s family due to limited health resources and high economic
costs [2]. Thereon during critical illness, part of the neuroendocrinealterations known as Non Thyroid Illness Syndrome (NTIS) or Low
T3 syndrome (LT3) characterized by low T3, Low or normal T4,
high rT3 and normal TSH [3–5] have been related with disease’s
severity and mortality in ICU setting [6–8]. However, the patho-
physiology of LT3 is complex and not well understood due to the
interaction of multiple factors during critical illness [9–14]. Thus
release of high levels of pro-inflammatory cytokines during the
acute response of critical illness have been reported to be related
and possibly cause NTIS [15–17]. Furthermore, previous studies
have demonstrated that pro-inflammatory cytokines and anti-
inflammatory cytokines blood concentration are correlated with
disease’s severity and mortality as well, but mainly in septic
patients [18–20]. Nevertheless, none study that analyze this
biomarkers in the same patient have been done. Therefore in this
prospective study, we attempt to evaluate the ability of thyroid
hormones, cytokines (IL-6 and IL-10), and albumin as predictors
of mortality in conjunction with APACHE II score in critically ill
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between these variables.
2. Materials and methods
2.1. Patients
This prospective and observational research was conducted at
Emergency Intensive Care Unit (EICU), of Xiangya Hospital – Cen-
tral South University, from August to December of 2014 with the
approval of the local Ethics Committee and written informed
consent from each patient.
During that period, 340 patients age 18 and older were admit-
ted to EICU, and all were screened for underlying thyroid disorders
by detailed medical record, physical examination (including palpa-
tion of the thyroid gland), blood test for thyroid hormones and
thyroid antibodies at EICU admission (following the declaration
of Helsinki). Their APACHE II score was also recorded within 24 h
of admission. Patients with: previous or new diagnosis of hypothy-
roidism, hyperthyroidism or its subclinical types, pregnancy,
breastfeeding condition, endocrine diseases (except Diabetes
Mellitus), duration of stay <24 h, and those transferred from other
hospitals with >36 h of hospitalization were all excluded, remain-
ing 79 patients.
2.2. Measurements
For patients that met the inclusion criteria, blood samples
were collected prior to interventions or therapy that could
potentially interfere or alter serums level of thyroid hormones or
cytokines, ‘‘ECLIA immune assay” detection kits via Electro-
Chemiluminescent Roche E 170 System (Roche Diagnostics
International Ltd., CH-6343 Rotkreuz, Switzerland) were used to
measure serum levels of FT3, FT4, and TSH and thyroid Normal
ranges of our laboratory were 2.8–7.1 pmol/L; 12–22 pmol/L, and
0.27–4.2 IU/L for FT3, FT4, and TSH respectively.
For cytokines’ blood concentration measurement, blood sam-
ples were obtained after 24 h of EICU admission, centrifuged at
2000 rpm  10 min; plasma was separated and frozen at 80 Cel-
sius until the time of the assay according to standard recommenda-
tions for cytokines’ assessment in blood samples [21–23]. ‘‘Sunny
Elisa Human IL-6 and IL-10 test” Multisciences (Hangzhou Lianke
biotechnology Ltd. China), were used to assess cytokines’ concen-
tration and measured by Colorimetric Reader GEN5-Biotek
(Bioteck instruments Inc., Beijing, China), minimum detectable
cytokine levels for IL-6 and IL-10 were <0.37 pg/ml. Interpolation
to the standard curve of the measurements were obtained
through linear regression by GraphPad Prism software version 6Table 1
General data: blood concentration of biomarkers by reason of admission to EICU.
Admission reasons n Age FT3
2.8–7.1 pmol/L
FT4
12–22 pmol/L
TSH
0.27–4
Neurologic 5 66 1.70 12.67 1.30
Polytraumatism 8 53 2.02 10.88 0.95
Cardiologic 11 60 2.22 13.48 1.26
Respiratory 9 60 2.30 16.20 0.99
Gastrointestinal 7 54 1.99 10.97 0.68
Metabolic 3 34 1.87 11.93 0.90
Sepsis 10 53 1.81 12.07 0.91
Hematologic 12 53 1.88 13.41 0.96
Renal 10 59 2.11 11.72 2.06
Others 4 47 2.46 10.88 1.79
Mean concentration values, the superior row shows the normal range values.
a Reference of basal concentration for IL-6 and IL-10 in healthy individual. S: Survivo(Inc. California, United States). Reference of cytokines levels in
healthy individuals were taken fromMaier et al. [24], whose values
are 70 pg/ml and 30 pg/ml for IL-6 and IL-10 respectively.2.3. Statistical analysis
Data is presented in means and 95% Confidence Interval (CI).
Variable’s mean were compared between survivors and non-
survivors. Data that did not show a normal distribution due to
extreme skewness was ranked and transformed to normal distri-
bution (ND) before applied t-test analysis. The determination of
correlations between variables were done by Pearson’s correlation
test; in order to set the critical point to predict mortality for
APACHE II, TH, IL-6, IL-10 and albumin levels Receiver Operating
Characteristic Curve was applied, results are presented as area
under the curve (AUC) with sensitivity and specificity. Independent
mortality predictors’ assessment was done by multivariate binary
logistic regression, after weight the cases and step wise input. All
data were analyzed using Statistical Package for Social Sciences
(SPSS) version 18 software (SPSS Inc., Chicago, IL, United States),
with significance of any p < 0.05.3. Results
3.1. General data
Of the 79 patients, 28 were females and 51 males. Average age
was 53 ± 3 years old, with age range from 18 to 82. Table 1 shows
the blood concentration of biomarkers by reason of admission to
EICU. Non-survivors’ age range was from 49 to 79 years old. The
average of length of stay (LOS) in EICU for non-survivors was
2 days and for survivors 4 days. In-ward LOS for survivors was
12 days, and for none survivors 5 days. Mortality rate within
28 days was 19% with a survival rate of 81%.3.2. Comparisons
Using the student t-test, the mean values obtained in the entire
cohort were compared first with the normal range and later
between survivors and non-survivors. Compared to survivors,
non-survivor were older (p = 0.008), with higher APACHE II score
(p = 0.003), higher IL-6 plasma levels (p = 0.03), higher IL-10
plasma levels (p = 0.004), and lower albumin serum levels
(p = 0.007) (Table 2). Only FT3 was slightly low in the entire cohort
studied (p = 0.000), however this value did not show any statistical
difference between survivors and non-survivors. FT4 and TSH were
both within normal range (Table 1)..2 IU/L
Albumin
40–55 g/L
aIL-6
70 pg/ml
aIL-10
30 pg/ml
APACHE II
P15
S N-S
32.80 168.30 54.94 20.03 4 1
34.75 178.77 46.78 14.88 8
33.44 164.47 40.08 16.27 10 1
28.88 261.01 17.37 19.44 7 2
26.75 209.27 56.63 10.84 6 1
29.85 324.93 109.02 22.00 3
26.54 250.37 188.72 19.34 4 6
26.69 204.46 189.78 20.61 10 2
34.65 194.48 79.82 19.82 8 2
34.29 108.39 16.70 13.25 4
rs, NS: none survivors.
Table 2
Comparison of mean values using t-test (2-tail) n = 79.
Entire cohort p1 value
df-78
Survivors (81%)
n = 64
95% C.I. Non survivors (19%)
n = 15
95% C.I. p2 value
df-77
Age in years 53 52 ±4 60 ±5 0.008
APACHE IIa 17 0.042 15 ±3.52 21 ±1.52 0.000
FT3 (pmol/L) 2.00 0.000 2.05 ±0.15 1.96 ±0.21 0.403
FT4 (pmol/L) 12.32 3.63 12.09 ±1.62 13.32 ±1.6 0.77
TSH (IU/L) 1.13 0.000 1.12 ±0.20 1.17 ±0.58 0.827
IL-6 (pg/ml)a 195.28 0.000 184.73 ±45.12 240.03 ±28.89 0.017
IL-10 (pg/ml)a 66 0.028 43.83 ±71.81 159.98 ±34.20 0.000
Albumin (g/L) 32 0.000 32.84 ±1.8 27.04 ±3.77 0.000
p1 Comparison between normal ranges and the entire cohort; p2 Comparison between S and N-S; (df) degrees of freedom. C.I. Confidence Interval.
a Compared with the physiological reference in healthy individual, critical value from AUC.
Fig. 1. Scatter dots of correlations, important percentage of the dots are near to the base line showing significant correlation. (a) High IL-6 has inverse correlation with
albumin. (b) High IL-10 show inverse correlation with albumin. (c) High IL-10 has inverse correlation with FT3. (d) Low albumin has direct correlation with FT3.
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In the entire cohort, APACHE II score had direct correlation with
mortality (r2 = 0.409 p = 0.000). High IL-6 levels showed a direct
correlation with IL-10 (r2 = 0.269 p = 0.017), and negative correla-
tion with albumin (r2 = 0.437 p = 0.000) (Fig. 1a). Meanwhile high
IL-10 levels had a negative correlation with FT3 (r2 = 0.290
p = 0.010) and albumin (r2 = 0.416 p = 0.000) (Fig. 1b and c).Hence, low albumin levels had a direct correlation with FT3 levels
(r2 = 0.264 p = 0.022) (Fig. 1d).
3.4. Independent predictors
The results of multivariate binary logistic regression showed
that IL-10, albumin and APACHE II were independent mortality
predictors. This analysis also showed that the model of predictors
Table 3
Multivariate logistic regression, odds ratio of variables for predicting mortality in EICU.
Variables B S.E. Wald df P value OR 95% C.I. for OR
Lower Upper
APACHE_II 0.224 0.068 10.986 1 0.001 1.251 1.096 1.428
Interleukin_10ND 0.008 0.003 7.037 1 0.008 1.008 1.002 1.015
Albumin_ND 0.158 0.057 7.647 1 0.006 0.853 0.763 0.955
Constant 3.427 2.480 1.909 1 0.167 0.032
Table 4
Area under the curve of variables and critical values to predict EICU mortality.
Variable AUC-ROC P value Cutoff value Sensitivity (%) Specificity (%)
APACHE II 0.753 0.002 P15 80 56
IL-10 0.750 0.003 P114 73 72
Albumin 0.721 0.010 632 79 54
IL-6 0.669 0.043 P189 80 55
FT3 0.549 0.570 2.02 53 52
Predictor model 0.897 0.000
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from 51% only by chance to 85% with the predictors.
A test of the full model (IL-10, albumin and APACHE II) showed
a significant goodness of (P = 0.000) and good calibration (Hosmer
and Lemeshow p = 0.109). Table 3 provides the odds for each
independent predictor.3.5. Critical value to predict mortality
The maximum values of APACHE II scores, IL-10 and the mini-
mum levels of albumin showed significance (p < 0.05) and a good
(0.70–0.79) AUC (Table 4 and Fig. 2a and b). Meanwhile the maxi-
mum levels of IL-6 showed significance as well (p = 0.043) but a
moderate (0.60–0.69) AUC. Despite the sensitivity and specificity
to predict mortality were similar for APACHE II scores and IL-6,
only IL-10 showed high sensitivity and specificity (Table 4).
The prediction model that included APACHE II scores, IL-10,
Albumin, showed a very good AUC (0.897) and significance
(p = 0.000) (Table 4 and Fig. 2c).4. Discussion
To our best knowledge, this is the first study that compares the
ability of these variables (IL-6, IL-10, FT3 and albumin) predicting
mortality at EICU admission in case-mix critically ill patients. The
present study of 79 unselected critically ill patients found that
the low FT3 serum levels did not show any significant difference
between survivors and non-survivors. However, as shown by the
multivariate logistic regression test, IL-10 and albumin and
APACHE II scores were independent mortality predictors. This
model also showed to improve the mortality prediction from
51% only by chance to 85% with a significant goodness of fit
(p = 0.000) and good calibration (Hosmer and Lemeshow
p = 0.109) [50]. The ROC evaluation based on the classification of
Keegan [50] for scoring systems showed that the maximum values
of APACHE II score, IL-10, and lowest albumin values had a good
AUC (0.70–0.79) while the maximum IL-6 values showed a moder-
ate (0.60–0.69) predictive value for EICU mortality. Meanwhile the
lowest values of FT3 did not have any predictive value for mortality
at EICU admission.
Previous studies that have reported the relevance of low T3 as
mortality predictors in ICU patients [30,31], did not consider the
relationship of TH with albumin and cytokines as confounding fac-
tors. Thus our results are similar to other studies that did not find
any predictive value of Low T3 or FT3 at ICU admission [32,33].An alternative explanation for this finding may be attributed to
the pathophysiology of LT3. As stated before, NTIS is a common
endocrinal alteration that occurs during the acute and chronic
phase of critical illness [3–5]. However several authors stated that
factors such as, fasting with subsequent depletion of selenium,
leptin and ATP, inhibit the functions of the thyroid deiodinases
(D1, D2, D3) that metabolize TH, causing lower T3 blood levels
commonly seen in critical patients [9–14]. Moreover, several drugs
used in ICU setting such as dopamine, amiodarone, furosemide,
etc., and free fatty acid as well [25,26], all competing with the
thyroid hormones to bind TBG, transthyretin and albumin. Addi-
tionally these carriers can be found frequently decreased in critical
illness as demonstrated by Afandi et al. [27]. Hence, it is important
to note that during the acute critical illness other hormones that
are massively released (i.e., cortisol) can have an inhibitory effect
in TSH that finally leads to LT3 [14,28].
One study in fatal patients with head injury by Zhou et al. [29]
found that TT3 decreased to its lowest levels at 96 h after ICU
admission, showing that the decreasing levels of TH in critical
illness is a progressive and dynamic process. This could explain
the lack of significance of low FT3 in our study between survivors
and non-survivors at EICU admission.
The fact that low albumin showed a direct correlations with FT3
(r2 = 0.264, p = 0.022) is quite surprising. Theoretically, free thyroid
hormones are the unbound fraction available to enter directly into
the cell to exert its effect and regulate TH feedback. Moreover it has
been postulated that the concentration free thyroid hormones is
inversely proportional to the concentration of unoccupied TT4/
TT3-TBG binding sites [34,35], therefore, drugs or other proteins
that bind TBG will decrease the free fraction of TH. Hence, hypoal-
buminemia that is commonly seen in critically ill patients might be
interpreted as a marker of protein-calorie malnutrition causing
depletion of amino acids and ATP necessary for the functions of
the deiodinases to convert T4 to T3 that influences in the low
FT3 levels [36].
In the other hand, cytokines such as TNF-a and IL-6 and IL-10
actively increased during the acute phase of critical illness,
decrease the transcription of mRNA necessary for the synthesis
of albumin in the hepatocyte by a nucleotide polymorphism in
the promoting region of cytokines [36–38] this could be supported
by the negative correlation with IL-6 (r2 = 0.437 p = 0.000) in our
study. However the nature of the negative correlation of IL-10 with
albumin (r2 = 0.416 p = 0.000) is currently unknown. Therefore it
will remain for future study the accuracy of these correlations in
critical illness, in order to assess its potential use as inexpensive
marker of cytokines levels.
Fig. 2. AUC of mortality prediction. (A) Variables with the highest values to predict mortality. (B) Variables with the lowest values to predict mortality. (C) Model of the
multivariate logistic regression with the all the independent predictor into the model.
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tality predictor. During critical illness low albumin levels reflect
visceral status, with consequent decrease in the protective
functions of albumin such as plasma oncotic pressure regulator,
antioxidant, antiplatelet agent, endothelial stabilization,
immunomodulation and as protein carrier, thus most of the reports
with wide data en patients with ESRD showed that low albumin
was the most powerful independent predictor [37,39,40], however
our study toke multiple cases to asses mortality.
As we expected, cytokines IL-6 and IL-10 levels were significant
higher, firstly in the entire cohort (p < 0.05) and secondly in non-
survivors (p < 0.05). It is well know that cytokines such as IL-1,
TNF-a, IL-6 and IL-8 are produced as part of the initial immune
response caused by systemic illness, trauma, intoxication or skin
burn. However, IL-1 and TNF-a, are almost undetectable in blood
due to their low concentrations and short life, thus, studies stated
that IL-1 and TNF-a act synergistically and enhance the production
of IL-6 and IL-8 [41], but only IL-6 is produced in large quantity
that allow its plethoric effects involved in several neuroendocrine
changes [41–43]. Hence, IL-6 has been demonstrated to cause
inhibition of thyroid deiodinase especially D1, D2 and D3 by the
increase of ROS and depletion of the intracellular co-factor
glutathione [44]. The evidence for other cytokines commonly pro-
duced during critical illness, such as IL-1, TNF-a, IFN-c and IL-8,
suggested that it does not have any effect or relationship with
LT3, although this fact might be attributed to difficult translation
from cellular or animal models to human trials [17,45], thus our
study did not include the previous cytokines mentioned.
Despite the lack of correlation of IL-6 with FT3 in this study, it
does not exclude the cause-effect relationship of cytokines and
NTIS supported by previous studies [41–44] and might be attribu-
ted to the limited number of patients in our study. However the
negative correlation of high IL-10 and FT3 (p = 0.010) would at
least statistically suggest that IL-10 is related with NTIS in our
study, similarly found in patients with chronic renal failure [46].
Finally it is notable that in our study IL-10 proved to be a strong
independent predictor of mortality similarly to previous studies
[51,52]. This fact might be attributed to its potent inhibitory effect
on proinflammatory cytokines from immune cells that cause endo-
crine changes as explained early, and higher IL-10 levels suppress
the immune system exposing the patients to a variety of nosoco-
mial infection during critical illness leading to death [47–49].
Thus this study has demonstrated that cytokines IL-6, IL-10, and
albumin are more reliable predictors of disease severity and
mortality. When combined with APACHE II score, these markers
will improve mortality prediction in case mix acute critical
patients compared with thyroid hormones decrease alone.4.1. Limitations
Some limitations in this study merit consideration. First, the
sample size of the population studied (survivors and non-
survivors) was small limiting the statistical power. Second we
measured the variables only at EICU admission; serial measure-
ments that include multiple cytokines and cytokine’s mRNA
sequences will provide more robust evidence to assess the
predominant predictor.5. Conclusions
Our study showed that IL-6 and IL-10 are correlated with Low
FT3 and hypoalbuminemia. Thyroid hormones assessed at EICU
admission did not have any predictive value in our study. And
finally, high levels of IL-6 and IL-10 in conjunction with albumin
could improve our ability to evaluate disease’s severity and predictmortality in the critically ill patients. When use in combination
with APACHE II scores, our model showed improved mortality
prediction.
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